Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 5 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors at 2 institutions in 1 country.
Catarina Miranda-LourençoInstituto de Farmacologia e Neurociências, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.ORCID 0000-0002-9633-7999
Jéssica RosaInstituto de Farmacologia e Neurociências, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.
Nádia ReiInstituto de Farmacologia e Neurociências, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.ORCID 0000-0003-0131-0126
Rita F BeloInstituto de Farmacologia e Neurociências, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.ORCID 0000-0002-4553-3455
Ana Luísa LopesLaboratório de Farmacologia e Neurobiologia/MedInUP, Instituto de Ciências Biomédicas Abel Salazar-Universidade do Porto (ICBAS-UP), 4050-313 Porto, Portugal.
Diogo SilvaLaboratório de Farmacologia e Neurobiologia/MedInUP, Instituto de Ciências Biomédicas Abel Salazar-Universidade do Porto (ICBAS-UP), 4050-313 Porto, Portugal.
Cátia VieiraLaboratório de Farmacologia e Neurobiologia/MedInUP, Instituto de Ciências Biomédicas Abel Salazar-Universidade do Porto (ICBAS-UP), 4050-313 Porto, Portugal.
Teresa Magalhães-CardosoLaboratório de Farmacologia e Neurobiologia/MedInUP, Instituto de Ciências Biomédicas Abel Salazar-Universidade do Porto (ICBAS-UP), 4050-313 Porto, Portugal.
Ricardo ViaisInstituto de Farmacologia e Neurociências, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.
Paulo Correia-de-SáLaboratório de Farmacologia e Neurobiologia/MedInUP, Instituto de Ciências Biomédicas Abel Salazar-Universidade do Porto (ICBAS-UP), 4050-313 Porto, Portugal.ORCID 0000-0002-6114-9189
Ana M SebastiãoInstituto de Farmacologia e Neurociências, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.
Maria J DiógenesInstituto de Farmacologia e Neurociências, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.
University of Lisbon · PTUniversidade do Porto · PT
Funding
Association Française du Syndrome de Rett N.AFaculdade de Medicina da Universidade de Lisboa/CHLN Gapic (project no. 20190017Fundação para a Ciência e Tecnologia 01-0145-FEDER-031929Fundação para a Ciência e Tecnologia FCT SFRH/BD/118238/2016Fundação para a Ciência e Tecnologia UID/BIM/4308/2019Fundação para a Ciência e Tecnologia UID/BIM/50005/2019Fundação para a Ciência e Tecnologia UIDP/04308/2020Twinnig action - Synanet N.AUniversity of Lisbon BD2015
6 · The paper itself
Abstract
Rett Syndrome is an X-linked neurodevelopmental disorder (RTT; OMIM#312750) associated to
Indexed as
Brain-Derived Neurotrophic FactorRett SyndromeAdenosineAnimalsCross-Sectional StudiesDisease Models, AnimalFemaleHumansMethyl-CpG-Binding Protein 2MiceMice, KnockoutAdenosineBrain-Derived Neurotrophic FactorMecp2 protein, mouseMethyl-CpG-Binding Protein 2adenosineBDNFMecp2 heterozygous femalesRett syndrome
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Adenosinergic System and BDNF Signaling Changes as a Cross-Sectional Feature of RTT: Characterization of · full record | OpenQuestion